Welcome to our dedicated page for Evolution Global Acquisition C news (Ticker: EVOX), a resource for investors and traders seeking the latest updates and insights on Evolution Global Acquisition C stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Evolution Global Acquisition C's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Evolution Global Acquisition C's position in the market.
Evolution Global Acquisition Corp (NASDAQ: EVOX) announced that beginning December 3, 2025 holders of units issued in its November 12, 2025 IPO may elect to separately trade the Class A ordinary shares and warrants on the Nasdaq Global Market.
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant; each whole warrant permits purchase of one Class A ordinary share at an exercise price of $11.50. Separated shares and warrants will trade under EVOX and EVOXW; unsplit units will continue under EVOXU. No fractional warrants will be issued. Shareholders must instruct brokers to contact Continental Stock Transfer & Trust Company, the transfer agent, to effect separation.
EVOLUTION GLOBAL ACQUISITION CORP (EVOX) priced an upsized initial public offering of 21,000,000 units at $10.00 per unit on November 10, 2025, implying gross proceeds of $210 million. Units will trade on Nasdaq as EVOXU beginning November 11, 2025; once separated, shares and warrants are expected to trade as EVOX and EVOXW. Each unit contains one Class A share and one-half warrant; each whole warrant permits purchase of one share at $11.50. The offering is expected to close on November 12, 2025, subject to customary closing conditions, and includes a 45-day underwriter option to buy up to 3,000,000 additional units for over-allotments. The company is a SPAC focused on potential business combinations in the critical minerals sector.
FAQ
What is the current stock price of Evolution Global Acquisition C (EVOX)?
What is the market cap of Evolution Global Acquisition C (EVOX)?
